Eiger BioPharmaceuticals announces proposed public offering of common stock
Eiger BioPharmaceuticals announced it has commenced an underwritten public offering of its common stock. Eiger intends to grant underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering. October 22, 2018